Subscribe Now
 Already a subscriber? Log-in!
By subscribing to Laboratory Industry Report, each month you'll get an insider's view of the lab industry's most important business and financial trends, plus predictions for the coming year.
In each issue, you find:
- Comparative data on lab pricing
- Information and explanations describing how to deal with healthcare integration, capitation, technology advances, etc.
- Clear perspectives of how your firm is performing vs. the market at large How publicly-traded lab companies are performing and what their top executives earn
- Updates on late-breaking mergers & acquisitions.
Are you up on what's working—and what's not—for laboratories located in a variety of practice settings-hospital, commercial, group practice sites and network systems?
More importantly, do you know where to turn for business intelligence & insight when you need to know what's happening to key companies, how Wall Street views the industry, or the latest scoop on mergers, buyouts, consolidations and alliances?
Laboratory Industry Report is a must for everyone having a vital stake in today's competitive lab marketplace-owner, director, pathologist, CEO, COO, CFO, general manager, administrator, manager, marketeer, or vendor.
With Laboratory Industry Report, you'll get all the business news & insights which are accurate, objective, reliable, and authoritative. Gain a competitive edge for your company or institution today by subscribing today!
|
|
|
 |
 | LIR March 2007 (full PDF issue) |
| TOP OF THE NEWS
Quest buys HemoCue
BioReference to stay on as Horizon PPO provider
HOSPITAL LABS
ASCP survey finds labs lack in emergency preparedness
Washington Hospital Center Labs get ‘LEAN’
NEW ON THE SCENE
NeoGenomics opens West Coast lab
Aureon Laboratories
INSIDE THE LAB INDUSTRY
Molecular diagnostic conference highlights
CONTRACTS & COLLABORATIONS
PRL partners with KansasBio
FINANCIAL
Lab stocks up 6%
INDUSTRY BUZZ
See you at Outreach ‘07
Full Article |
| BREAKING NEWS: BioReference Reaches Accord With NJ’s Horizon |
| After publicly broadcasting its outrage at having been notified that Horizon Blue Cross Blue Shield of New Jersey (Newark, NJ) would terminate its longtime in-network provider relationship on March 31 as a result of a new agreement with LabCorp, BioReference Laboratories (Elmwood Park, NJ) announced on February 28 that it has reached an accord with the health insurer. As a result, Bio-Reference will remain as a lab services provider in Horizon’s PPO network.
Full Article |
| Quest Buys POC Testmaker HemoCue for $420m |
| Quest Diagnostics (Lyndhurst, NJ) is still busy snapping up specialized IVD companies. This time the focus is at the point-of-care (POC). Quest has purchased HemoCue (Angelholm, Sweden), which specializes in POC testing, from the private equity firm EQT II B.V. in a cash transaction valued at approximately $420 million. With annualized revenues of approximately $90 million, HemoCue is the leading international provider in POC testing for hemoglobin, with a growing share in glucose and microalbumin testing. Washington G-2 Reports estimates that POC testing represents a worldwide market of approximately $5.5 billion and is growing at approximately 10% per year.
Full Article |
| ASCP Survey Finds Labs Lack Confidence in Emergency Preparedness |
| Less than half of clinical laboratories believe that they could effectively respond in a hazardous chemical emergency, according to a survey of clinical laboratory directors and managers conducted by the American Society for Clinical Pathology (ASCP; Chicago, IL) and the U.S. Centers for Disease Control and Prevention (CDC). The survey results appear in the February issue of LABMEDICINE magazine, published by ASCP.
Full Article |
| Aureon Labs Combines Predictive Pathology, Personalized Medicine |
| Aureon Laboratories (Yonkers, NY) is betting on the powerful combination of predictive pathology and personalized medicine to advance clinical laboratory medicine. Although founded in 2001, the company is only now ramping up its commercial activity by applying "systems pathology" to develop predictive clinical tests for cancer, as well as to facilitate biopharmaceutical research and development.
Full Article |
| NeoGenomics Gets CLIA Certification for New West Coast Lab |
| NeoGenomics (Ft. Myers, FL) has received certification for its new laboratory in Irvine, California, under the Clinical Laboratory Improvement Act, as amended (CLIA) through inspection by the California Department of Health. This is the third laboratory for the molecular testing company, which also has locations in Fort Myers, Florida, and Nashville, Tennessee.
Full Article |
| Selecting Strategic Test Menus for Molecular Diagnostic Laboratories |
| Molecular testing can be a powerful revenue driver for clinical laboratories, but when is the right time to bring it onboard, and how do you choose which tests to offer? And once you’ve "gone molecular," how do you best integrate this type of testing into your laboratory and maximize returns? These were some of the key questions addressed at "Integrating MDx Into Your Lab," Washington G-2 Reports’ 2nd Annual Molecular Diagnostic Conference held in Tampa, Florida, last month.
Full Article |
| Washington Hospital Center Labs Get ‘LEAN’ |
| Quality manufacturing philosophy Six Sigma has been around a while, and now it’s being joined by LEAN as a method for streamlining productivity, increasing efficiency and quality, and ultimately resulting in better revenue streams. Washington Hospital Center, part of MedStar Health, has begun a systemwide LEAN initiative, including the WHC Department of Pathology & Laboratory Medicine (Washington, DC). In 2002, they began Six Sigma and in 2005 started LEAN.
Full Article |
| PRL Establishes Regional Collaboration With Kansas Biotech Group |
| PRL Central Laboratory Services (PRL; Overland Park, KS), a division of Physicians Reference Laboratory, has entered into a laboratory testing agreement with the Kansas Bioscience Organization (KansasBio; Lenexa, KS), a three-year-old trade association. Under the terms of the agreement, PRL will provide price incentives for safety and efficacy laboratory testing, toxicological testing, and employee health screening services to KansasBio and its member companies. KansasBio members include university laboratories; established pharmaceutical, animal health, and crop science companies; and entrepreneurial ventures, start-ups, and service providers in the biosciences.
Full Article |
| Lab Stocks Rise 6% Led by Monogram |
| The G-2 Laboratory Stock Index rose 6% in the five weeks ended February 23, with seven stocks up in price and four down. Year to date, the G-2 Index is up 7%, while the Nasdaq is up 4% and the S&P 500 is up 2%.
Full Article |
| See You at Outreach ‘07 |
| Don’t miss the 6th Annual Lab Outreach Conference: Optimizing Hospital and Health System Lab Outreach Performance, April 25 to 27, 2007, at the Atlanta Renaissance Concourse Hotel in Atlanta, Georgia. This year’s conference features a keynote address by Thomas Tiffany, Ph.D., the president and CEO of PAML, who will discuss how laboratory outreach can be a strategic growth driver for health systems.
Full Article |
|
|
Please choose an archived issue to view newsletter table of contents above
|
|
